Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Chronic Pulmonary Aspergillosis and Antifungal Drug Resistance of Aspergillus Spp. in Pulmonary Tuberculosis Patients in Uzbekistan

NCT05045391 is registered in ClinicalTrials.gov with Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan as lead sponsor.

NCT NCT05045391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05045391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Chronic Pulmonary Aspergillosis and Antifungal Drug Resistance of Aspergillus Spp. in Pulmonary Tuberculosis Patients in Uzbekistan
Lead sponsor
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2020
Completion date
December 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active tuberculosis, aspergillosis, chronic pulmonary aspergillosis, old tuberculosis, pulmonary tuberculoses